Pursuant to Regulations 30 and 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copy of Annual ....

Nectar Lifesciences Ltd has announced its 31st Annual General Meeting (AGM) and Annual Report for the financial year ended March 31, 2026. The AGM will be held on September 18, 2026, through video conferencing, and will consider various resolutions, including the re-appointment of Dr. Indu Pal Kaur as an Independent Director and the adoption of the standalone and consolidated financial statements.